Table 1.
Patient and disease characteristics at cabozantinib initiation.
| Nr | Age | Sex | Diagnosis | Primary Location |
Location of Recurrence |
|---|---|---|---|---|---|
| 1 | 17 | M | OS | radius | lung, bone, psoas |
| 2 | 19 | M | OS | tibia | local recurrence, lung |
| 3 | 20 | M | OS | humerus | lung |
| 4 | 23 | M | OS | femur | lung, kidneys, brain |
| 5 | 33 | F | PNET | adrenal gland | local recurrence, lung |
| 6 | 63 | M | OS | femur | lung |
| 7 | 66 | M | OS (RI) | mandible | local recurrence |
| 8 | 83 | M | OS | thoracic spine | local recurrence |
| 9 | 34 | M | ES | pelvis | local recurrence, lung, liver |
| 10 | 47 | M | OS | ilium | bone |
| 11 | 18 | M | ES | sacrum | lung |
| 12 | 25 | M | ES | thoracic spine | lung, pleura, muscle |
| 13 | 29 | F | OS | thoracic spine | NA |
| 14 | 24 | M | OS | femur | NA |
| 15 | 31 | M | ES | femur | lung |
| 16 | 33 | F | OS | tibia | lung |
N: number, M: male, F: female, OS: osteosarcoma, ES: Ewing sarcoma, RI: radiation-induced, NA: not available.